1. Effectiveness of polyene phosphatidylcholine and its combination with other drugs in patients with liver diseases based on real-world research
   Ying Li et al, 2022, Expert Review of Clinical Pharmacology CrossRef
2. Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet
   Mohamed El-Sherbiny et al, 2018, Chemico-Biological Interactions CrossRef
3. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis
   Xin Han et al, 2021, Pharmacology & Therapeutics CrossRef
4. Telmisartan prevents diet-induced obesity and preserves leptin transport across the blood-brain barrier in high-fat diet-fed mice
   Franziska Schuster et al, 2018, Pflügers Archiv - European Journal of Physiology CrossRef
5. Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
   Chun-Ye Zhang et al, 2023, World Journal of Hepatology CrossRef
6. Polyene Phosphatidylcholine Interacting with TLR-2 Prevents the Synovial Inflammation via Inactivation of MAPK and NF-κB Pathways
   Zixuan Xu et al, 2022, Inflammation CrossRef
7. Telmisartan improves the metabolic, hematological and inflammasome indices in non-alcoholic fatty liver infiltration: A pilot open-label placebo-controlled study
   Marwan S.M. Al-Nimer et al, 2019, Electronic Journal of General Medicine CrossRef
8. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
   Chang Meng et al, 2023, Open Life Sciences CrossRef
9. Leptin: an entry point for the treatment of peripheral tissue fibrosis and related diseases
   Yuexia Liu et al, 2022, International Immunopharmacology CrossRef
10. Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model
    Francielle Graus-Nunes et al, 2019, World Journal of Hepatology CrossRef
11. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways
    Ping-Cuo Suolang et al, 2019, Journal of Ethnopharmacology CrossRef
12. TLR-2-mediated metabolic reprogramming participates in polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization
    Ting-Ting Feng et al, 2020, Immunologic Research CrossRef
13. Effect of telmisartan and vitamin E on liver histopathology with non‐alcoholic steatohepatitis: A randomized, open‐label, noninferiority trial
    Shahinul Alam et al, 2020, JGH Open CrossRef
14. Studies on the Antiliver Injury of Effective Parts from Saururus chinensis by Rats and Mice Model In Vivo
    Chaonan Wang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef